Design
Review
Authors
Loading...
No immediate clinical role for Nav1.7 inhibitors; leaves open need for efficacy trials after patent activity.
This review provides a comprehensive summary of recent patent applications for Nav1.7 inhibitors, highlighting the intense interest in developing these compounds for inflammatory and neuropathic pain.
Sun et al. (2014) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: